Stockholder's Equity (Details 2) (USD $)	0 Months Ended	3 Months Ended	100 Months Ended					0 Months Ended
	Feb. 18, 2014	Mar. 31, 2014	Mar. 31, 2014	Dec. 31, 2013	Feb. 18, 2014 Weighted average	Dec. 31, 2013 Weighted average	Feb. 18, 2014 ContraVir Spin-off	Feb. 04, 2014 February 4, 2014 Private Placement ContraVir	Feb. 04, 2014 February 4, 2014 Private Placement ContraVir Warrants	Feb. 18, 2014 ContraVir	Feb. 18, 2014 ContraVir Spin-off	Mar. 27, 2014 ContraVir Loan Agreement	Jan. 09, 2014 ContraVir Loan Agreement	Oct. 18, 2013 ContraVir Loan Agreement	Aug. 29, 2013 ContraVir Loan Agreement	Jun. 05, 2013 ContraVir Loan Agreement
Stockholders' equity
Maximum amount the entity agreed to lend														$ 1,000,000		$ 500,000
Amount of advance to subsidiary													100,000	150,000	100,000	100,000
Interest rate (as a percent)																6.00%
Period of prior written notice for demanding payment of unpaid principal amount and all accrued but unpaid interest thereon at anytime after specified date																15 days
Repayment of advance by ContraVir												461,236
Gross proceeds		3,224,000	3,224,000					3,200,000
Expenses related to private placement								15,000
Number of units sold (in shares)								9,485,294
Number of shares of common stock per unit								1
Number of warrants per unit (in shares)								1
Number of common shares that can be acquired upon exercise of each warrant								0.5
Purchase price (in dollars per unit)								$ 0.34
Expiration period of warrant									6 years
Exercise price (in dollars per unit)					$ 5.359	$ 5.37			$ 0.37
Derivative liabilities related to Warrants		1,311,000	1,311,000	1,534,000					880,000
Shares of subsidiary distributed for each share of the entity's shares outstanding										0.0986
Assets
Cash							3,230,000
Prepaid expense							6,000
Total assets							3,236,000
Liabilities
Accounts payable and other liabilities							(107,000)
Note Payable to Synergy							(455,000)
Due to Synergy							(54,000)
Derivative financial instruments, at estimated fair value-warrants							(880,000)
Total Liabilities							(1,496,000)
Net assets							1,740,000
Decrease in non-controlling interest		$ 1,622,000									$ 1,600,000
Decrease in exercise price (in dollars per share)	$ 0.011
Warrants outstanding (in shares)		5,647,203	5,647,203	5,647,203					4,700,000